跳至主要内容
临床试验/NCT00599092
NCT00599092招募中不适用

Pituitary Tumor Surveillance: Pathogenetic Correlation

Cedars-Sinai Medical Center1 个研究点 分布在 1 个国家目标入组 1,250 人开始时间: 1997年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
1,250
试验地点
1
主要终点
Overall Survival (Longevity)

研究概览

简要总结

The purpose of this study is to observe predictors of pituitary tumor recurrence and markers of persistent disease activity in patients harboring pituitary mass lesions of all types.

详细描述

The purpose of this study is to observe predictors of pituitary tumor recurrence and markers of persistent disease activity through computerized collection of comprehensive demographic, therapeutic, pathologic and outcome information on patients harboring pituitary mass lesions of all types.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with confirmed pituitary disease

排除标准

  • patients who do not have confirmed pituitary disease

结局指标

主要结局

Overall Survival (Longevity)

时间窗: 20 years

Overall survival will be measured from study enrollment (or diagnosis, as applicable) to death from any cause. Survival status will be determined through electronic medical records and, if necessary, supplemented by publicly available death records (e.g., National Death Index).

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shlomo Melmed, MD

Professor of Medicine

Cedars-Sinai Medical Center

研究点 (1)

Loading locations...

相似试验